FDA NDC Directory · JSON-LD · Markdown

Sulfasalazine

NDC 11534-201 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerSunrise Pharmaceutical, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075339
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsSULFASALAZINE (500 mg/1)
Marketing started20251211
Package count2

External sources

Source: openFDA. Public-domain (CC0).